Fragment screening of massively parallel ligand arrays using the Carterra Ultra SPR platform

Fragment-based lead discovery (FBLD) demands technologies that can detect low-affinity interactions across vast chemical space, posing throughput and sensitivity challenges. Discover how high-throughput surface plasmon resonance (SPR) innovations dramatically expand ligand capacity, streamline hit-to-lead workflows, and enable simultaneous analysis of over 100 targets, accelerating decision-making in early-stage drug discovery.